European Polymer Journal, Journal Year: 2024, Volume and Issue: 209, P. 112924 - 112924
Published: March 11, 2024
Language: Английский
Life Sciences, Journal Year: 2024, Volume and Issue: 352, P. 122899 - 122899
Published: July 9, 2024
This comprehensive review provides an in-depth analysis of how nanotechnology has revolutionized cancer theragnostic, which combines diagnostic and therapeutic methods to customize treatment. The study examines the unique attributes, uses, difficulties linked different types nanoparticles, including gold, iron oxide, silica, Quantum dots, Carbon nanotubes, liposomes, in context In addition, paper progression nanotheranostics, emphasizing its uses precise medication administration, photothermal therapy, sophisticated such as MRI, CT, fluorescence imaging. Moreover, article highlights capacity nanoparticles improve effectiveness drugs, reduce overall toxicity body, open up new possibilities for treating by releasing drugs a controlled manner targeting specific areas. Furthermore, it tackles concerns regarding compatibility their potential harmful effects, significance continuous nanotherapeutic use medical treatments. finishes outlining future applications predictive oncology customized medicine.
Language: Английский
Citations
67
Carbohydrate Polymers, Journal Year: 2024, Volume and Issue: 330, P. 121839 - 121839
Published: Jan. 20, 2024
Language: Английский
Citations
30
Advanced Science, Journal Year: 2024, Volume and Issue: unknown
Published: July 3, 2024
Early-stage disease detection, particularly in Point-Of-Care (POC) wearable formats, assumes pivotal role advancing healthcare services and precision-medicine. Public benefits of early detection extend beyond cost-effectively promoting outcomes, to also include reducing the risk comorbid diseases. Technological advancements enabling POC biomarker recognition empower discovery new markers for various health conditions. Integration wearables with intelligent frameworks represents ground-breaking innovations automation operations, conducting advanced large-scale data analysis, generating predictive models, facilitating remote guided clinical decision-making. These substantially alleviate socioeconomic burdens, creating a paradigm shift diagnostics, revolutionizing medical assessments technology development. This review explores critical topics recent progress development 1) systems solutions physiological monitoring, as well 2) discussing current trends adoption smart technologies within settings developing biological assays, ultimately 3) exploring utilities platforms discovery. Additionally, translation from research labs broader applications. It addresses associated risks, biases, challenges widespread Artificial Intelligence (AI) integration diagnostics systems, while systematically outlining potential prospects, challenges, opportunities.
Language: Английский
Citations
24
Journal of Drug Delivery Science and Technology, Journal Year: 2024, Volume and Issue: 95, P. 105599 - 105599
Published: March 26, 2024
Despite considerable progress in patient care, the global incidence of various cancer types continues to rise. Developing safer and more efficient anti-cancer treatment approaches are great interest. In recent decades, nanotechnology has emerged as a promising innovative medical approach for diagnosis treatment. However, nanomedicine advances, it is important understand address challenges. Herein, we identify gaps current understanding effectiveness on clinical outcomes provide an outlook improved application medicine. We discuss use different nanoparticles therapy impact efficiency existing treatments, such chemotherapeutic, anti-angiogenic, immunotherapeutic drugs, radiotherapy. Additionally, update status trials nanoparticle-based treatments provided.
Language: Английский
Citations
21
Small Science, Journal Year: 2024, Volume and Issue: 4(3)
Published: Jan. 22, 2024
Despite significant advancements in medical technology, cancer remains the world's second‐leading cause of death, largely attributed to late‐stage diagnoses. While traditional detection methodologies offer foundational insights, they often lack specificity, affordability, and sensitivity for early‐stage identification. In this context, development biosensors offers a distinct possibility precise rapid identification biomarkers. Carbon nanomaterials, including graphene, carbon nitride, quantum dots, other carbon‐based nanostructures, are highly promising detection. Their simplicity, high sensitivity, cost‐effectiveness contribute their potential field. This review aims elucidate emerging carbon‐nanomaterial‐based early diagnosis. The relevance various biosensor mechanisms performance physicochemical properties nanomaterials is discussed depth, focusing on demonstrating broad creating biosensors. Diverse techniques, such as electrochemical, fluorescence, surface plasmon resonance, electrochemiluminescence, quartz crystal microbalance, emphasized At last, summary existing challenges future outlook field elaborated.
Language: Английский
Citations
20
Artificial Intelligence Review, Journal Year: 2025, Volume and Issue: 58(4)
Published: Jan. 25, 2025
Language: Английский
Citations
4
Biosensors, Journal Year: 2023, Volume and Issue: 13(3), P. 398 - 398
Published: March 18, 2023
Cancer is one of the major public health issues in world. It has become second leading cause death, with approximately 75% cancer deaths transpiring low- or middle-income countries. causes a heavy global economic cost estimated at more than trillion dollars per year. The most common cancers are breast, colon, rectum, prostate, and lung cancers. Many these can be treated effectively cured if detected primary stage. Nowadays, around 50% late stages, to serious complications death. Early diagnosis diseases substantially increases efficient treatment high chances survival. Biosensors potential screening methodologies useful early biomarkers. This review summarizes recent findings about novel biomarkers their advantages over traditional biomarkers, biosensing diagnostic methods for them; thus, this may helpful recognition monitoring response various human
Language: Английский
Citations
30
Microsystems & Nanoengineering, Journal Year: 2023, Volume and Issue: 9(1)
Published: Oct. 5, 2023
Abstract With the annual increases in morbidity and mortality rates of tumors, use biomarkers for early diagnosis real-time monitoring tumor cells is great importance. Biomarkers used cell detection body fluids include circulating cells, nucleic acids, protein markers, extracellular vesicles. Among them, DNA, exosomes have high potential prediction, diagnosis, prognosis diseases due to large amount valuable information on characteristics evolution; addition, situ telomerase miRNA living has been topic extensive research understand development real time. Various techniques, such as enzyme-linked immunosorbent assays, immunoblotting, mass spectrometry, widely these markers. markers based electrochemical biosensors fluorescence signal analysis highly preferred because its sensitivity, rapid portable operation. Herein, we summarize recent progress using biosensors, outline current status discuss technical challenges their practical clinical application provide a reference new marker methods.
Language: Английский
Citations
24
Journal of Clinical Medicine, Journal Year: 2024, Volume and Issue: 13(14), P. 4189 - 4189
Published: July 18, 2024
The leading cause of cancer deaths worldwide is attributed to non-small cell lung (NSCLC), necessitating a continual focus on improving the diagnosis and treatment this disease. In review, latest breakthroughs emerging trends in managing NSCLC are highlighted. Major advancements diagnostic methods, including better imaging technologies utilization molecular biomarkers, discussed. These have greatly enhanced early detection personalized plans. Significant improvements patient outcomes been achieved by new targeted therapies immunotherapies, providing hope for individuals with advanced NSCLC. This review discusses persistent challenges accessing treatments their associated costs despite recent progress. Promising research into therapies, such as CAR-T therapy oncolytic viruses, which could further revolutionize treatment, also aims inform inspire continued efforts improve patients globally, offering comprehensive overview current state future possibilities.
Language: Английский
Citations
11
Materials Horizons, Journal Year: 2024, Volume and Issue: unknown
Published: Jan. 1, 2024
In this study, we reported a flower-like Cu 2 O@Ag SERS substrate for distinguish three types of cancer cells from white blood by using machine learning-assisted LDA, after separating samples via microfluidic chip.
Language: Английский
Citations
11